Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 13, 2023
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
Thu, October 12, 2023
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
Oren Livnat Reiterated (VRCA) at Strong Buy and Held Target at $12 on, Oct 12th, 2023
Oren Livnat of HC Wainwright & Co., Reiterated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $12 on, Oct 12th, 2023.
Oren has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $10 on, Wednesday, August 23rd, 2023
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $14 on, Tuesday, July 25th, 2023
